Literature DB >> 27222411

Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis.

Jia Yao1,2, Le Chang2, Lili Yuan2, Zhongping Duan3.   

Abstract

Malnutrition and small intestinal bacterial overgrowth (SIBO) is frequently present in patients with liver cirrhosis (LC). However, the direct relationship between SIBO and nutrition status in the LC patients has not been elucidated. The aim of this study was to investigate whether there was an association between nutrition status, evaluated by the subjective global assessment (SGA) and SIBO in patients with Hepatitis B virus (HBV) or hepatitis C virus (HCV) related cirrhosis. A total of 120 patients with HBV or HCV-related cirrhosis and 30 healthy controls were included. Nutritional status was determined according to SGA and anthropometry. All patients and healthy controls underwent a glucose hydrogen breath test for SIBO. The prevalence of malnutrition for the patients with HBV or HCV related cirrhosis ranged 19.4%-60% in China. The highest prevalence of malnutrition was detected by SGA, the lowest by triceps skinfold thickness. The frequency of SIBO was significantly higher in the malnourished (SGA-B/C) than in the well-nourished (SGA-A) patients with HBV or HCV related cirrhosis [41/72 (56.9%) vs 12/48 (25.0%) (p=0.001)]. Univariate analysis showed that SIBO, ascites, and Child-Turcotte-Pugh (CTP) class were associated with malnutrition. Multivariate analysis demonstrated that SIBO [odds ratio (OR) 8.10; p=0.002] and ascites (OR 4.56; p=0.022) were independently associated with the occurrence of malnutrition (SGA-B/C) in the same subjects. SIBO is independently related to the occurrence of malnutrition (SGA-B/C) in patients with HBV or HCV cirrhosis. We deduce that SIBO may play an important role in nutrition status in patients with HBV or HCV cirrhosis.

Entities:  

Mesh:

Year:  2016        PMID: 27222411     DOI: 10.6133/apjcn.2016.25.2.06

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  14 in total

1.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

2.  Gut dysbiosis and body composition in cirrhosis.

Authors:  Roman Maslennikov; Vladimir Ivashkin; Aliya Alieva; Elena Poluektova; Anna Kudryavtseva; George Krasnov; Maria Zharkova; Yuri Zharikov
Journal:  World J Hepatol       Date:  2022-06-27

3.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Hepatol Int       Date:  2018-10-04       Impact factor: 6.047

Review 4.  The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-07       Impact factor: 46.802

5.  Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes.

Authors:  Shahab Abid; Muhammad Kamran; Adeel Abid; Nazish Butt; Safia Awan; Zaigham Abbas
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

Review 6.  Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

7.  The Challenges of Nutritional Assessment in Cirrhosis.

Authors:  Alessio Molfino; Sheeva Johnson; Valentina Medici
Journal:  Curr Nutr Rep       Date:  2017-07-18

Review 8.  A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  Gastroenterol Res Pract       Date:  2017-08-13       Impact factor: 2.260

Review 9.  Molecular Targets in Hepatocarcinogenesis and Implications for Therapy.

Authors:  Meng-Yu Wu; Giuo-Teng Yiang; Pei-Wen Cheng; Pei-Yi Chu; Chia-Jung Li
Journal:  J Clin Med       Date:  2018-08-13       Impact factor: 4.241

10.  Intestinal Microbiota of Grass Carp Fed Faba Beans: A Comparative Study.

Authors:  Lei Zhou; Ke-Tao Lin; Lian Gan; Ji-Jia Sun; Chang-Jun Guo; Li Liu; Xian-de Huang
Journal:  Microorganisms       Date:  2019-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.